Skip to content
AnalystLens

Mondelez International, Inc. 8-K Report, Financial Results (Oct 29, 2024)

Reports
Earnings & Results·Exhibits & Filings
Filing Date
Filed October 29, 2024
Period End
October 29, 2024
Security
MDLZ
In the record · 2016–202610-K1110-Q328-K184

MDLZ filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 184 current reports (8-K) between 2016 and 2026.

  1. Restructuring8-K · Sep ’18Sep ’18
  2. Material agreement8-K · Jun ’20Jun ’20
  3. Material agreement8-K · Jul ’22Jul ’22
  4. Leadership change8-K · Jun ’26Jun ’26

Summary

Summary of the 8-K filed October 29, 2024. Cited figures are marked; the original filing is the authoritative source.

Mondelēz International (MDLZ) reported third-quarter 2024 results on October 29, 2024, showing top-line acceleration on an organic basis alongside a sharp drop in GAAP profitability.

Reported net revenues rose 1.9% to $9.2 billiona, while Organic Net Revenue grew 5.4%, driven by higher net pricing (+5.1 pts) and modestly positive volume/mix (+0.3 pts). Reported diluted EPS fell 12.5% to $0.63, largely because of unfavorable mark-to-market derivative swings ($707 million unrealized losses), $153 million of intangible asset impairments, and costs tied to the ERP system implementation and the 2023 gum divestiture. On a non-GAAP basis, Adjusted EPS grew 28.6% on a constant currency basis to $0.99, supported by strong pricing, productivity-driven manufacturing savings, fewer shares outstanding, lower interest expense and lower taxes.

The quarter also included a $350 millionb reduction in the fair value of Clif Bar contingent consideration, which was a meaningful one-time benefit to GAAP operating income and EPS. Investors should therefore look past the headline GAAP decline and weigh the Adjusted metrics against the GAAP figures. Year-to-date, operating cash flow was $3.5 billion and Free Cash Flow was $2.5 billion, and the company returned $2.9 billion to shareholders through dividends and buybacks in the first nine months.

Management reaffirmed its 2024 outlook: Organic Net Revenue growth at the upper end of 3–5%, high single-digit Adjusted EPS growth on a constant currency basis, and Free Cash Flow of at least $3.5 billionc. Currency is expected to reduce net revenue growth by about 1.5% and Adjusted EPS by $0.11. The company also agreed to acquire a majority stake in Evirth, a Chinese cakes and pastries manufacturer, expected to close in Q4 2024, which management frames as a move to reshape the portfolio toward faster-growing categories.

Key Highlights

  1. Organic Net Revenue grew 5.4% in Q3 2024, led by pricing of +5.1 pts and volume/mix of +0.3 pts; reported net revenues rose 1.9% to $9,204 million.
  2. Adjusted EPS rose 28.6% on a constant currency basis to $0.99, while GAAP diluted EPS fell 12.5% to $0.63 due largely to mark-to-market derivative losses and impairments.
  3. GAAP gross profit margin fell 610 bps to 32.6%, but Adjusted Gross Profit margin expanded 230 bps to 40.5% on pricing and productivity.
  4. GAAP operating income declined 16.4% to $1,153 million, including $153 million of intangible asset impairments and a $350 million favorable Clif Bar contingent consideration adjustment.
  5. Year-to-date Free Cash Flow reached $2.5 billion, and the company returned $2.9 billion to shareholders via dividends and buybacks through nine months.
  6. 2024 guidance was reaffirmed: Organic Net Revenue growth at the upper end of 3–5%, high single-digit constant-currency Adjusted EPS growth, and Free Cash Flow of $3.5 billion or more.
  7. Agreed to acquire a majority stake in Evirth, a Chinese cakes and pastries manufacturer, expected to close in Q4 2024, subject to regulatory approval.

Frequently Asked Questions

  1. Why did GAAP diluted EPS decline 12.5% when Adjusted EPS grew 28.6%?

    The gap is driven by items excluded from Adjusted EPS. The largest was a $707 million unrealized mark-to-market loss on commodity and currency derivatives, which hit GAAP results, along with $153 million in intangible asset impairments, ERP implementation costs, and lapping the 2023 gum divestiture. These were partly offset by a $328 million net benefit from acquisition contingent consideration adjustments, which is also excluded from Adjusted results.

  2. Is the Clif Bar contingent consideration gain a one-time benefit to earnings?

    Yes, it is largely a non-recurring benefit. The company reduced the fair value of the Clif Bar earn-out liability by $350 million after lowering its 2025–2026 forecasts. This flattered GAAP operating income and EPS in Q3, and it is excluded from Adjusted metrics, so investors should not treat it as a sustainable source of profit.

  3. How strong is the company's cash generation and balance sheet?

    Year-to-date operating cash flow was $3.45 billion and Free Cash Flow was $2.47 billion, up about 4% from the prior year. Net debt increased to $18.3 billion from $17.6 billion at year-end 2023, driven partly by short-term borrowings rising to $1.5 billion. Management still expects full-year Free Cash Flow of at least $3.5 billion.

  4. What are the main risks to the 2024 outlook?

    Management highlighted greater-than-usual volatility, including geopolitical uncertainty in Ukraine and the Middle East, commodity costs (notably cocoa), and currency. Currency translation is expected to reduce 2024 net revenue growth by about 1.5% and Adjusted EPS by $0.11. Continued pressure on commodity costs and the pace of recovery in impaired biscuit brands are additional risks.

  5. What does the Evirth acquisition mean for Mondelēz?

    The deal to acquire a majority stake in Evirth, a leading Chinese manufacturer of cakes and pastries, expands Mondelēz's presence in the fast-growing China baked goods category. Management says it will leverage the company's brands and distribution to develop more premium offerings. The transaction is subject to regulatory approval and is expected to close in Q4 2024. Its financial impact has not been quantified in this release.